Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 26, 2025

Orthotopic Kidney Auto-Transplantation in a Porcine Model Using 24 Hours Organ Preservation And Continuous Telemetry
Published on: August 21, 2020
Marry de Klerk1, Judith A Kal-van Gestel1, Dave Roelen2
1Erasmus Medical Center, Department of Internal Medicine, Transplantation Institute, Rotterdam, Netherlands.
This study evaluates a new kidney-exchange program called CIAT, which helps patients who are difficult to match for a transplant due to blood type or immune system barriers. By prioritizing specific patients and allowing certain incompatible transplants, the program successfully increased transplant rates for these individuals compared to existing options.
Area of Science:
Background:
Limited access to compatible organs remains a significant barrier for patients requiring renal replacement therapy. Many individuals face prolonged wait times due to blood type or immune system incompatibilities. Existing allocation systems often fail to address the needs of highly sensitized candidates effectively. That uncertainty drove the development of novel strategies to expand donor-recipient matching possibilities. Prior research has shown that traditional exchange models frequently exclude those with complex immunological profiles. No prior work had resolved how to integrate altruistic donors into these specific exchange frameworks efficiently. This gap motivated the creation of specialized programs designed to bypass standard matching constraints. The current landscape of transplantation requires innovative solutions to improve outcomes for these vulnerable populations.
Purpose Of The Study:
The primary aim was to evaluate the effectiveness of a computerized integration program in increasing transplantation options for difficult-to-match patients. Researchers sought to determine if this model could improve outcomes for highly-immunized and long-waiting candidates. The study addressed the limitations of existing allocation systems that often fail these specific groups. Investigators wanted to see if prioritizing certain patients could yield better results than standard approaches. They also explored whether allowing incompatible transplants could safely expand the pool of available organs. This work was motivated by the need to find alternatives for patients who face significant barriers to receiving a kidney. The team examined whether this strategy could function effectively within a local clinical environment. By assessing this pilot, the authors intended to provide evidence for optimizing current transplantation practices.
Main Methods:
The review approach involved a retrospective analysis of a local pilot program established between 2017 and 2022. Researchers examined data from 131 incompatible couples to assess transplant outcomes. They compared the performance of this specific initiative against all other available transplant pathways. The investigation focused on two distinct groups: highly-immunized candidates and long-waiting patients. Investigators applied strict eligibility criteria to manage the allocation of incompatible organs. They tracked the number of successful procedures, including compatible, blood-type incompatible, and human leukocyte antigen-incompatible transplants. The team evaluated the impact of prioritization policies on overall transplant rates. This methodology allowed for a comprehensive assessment of the program's effectiveness in a real-world clinical setting.
Main Results:
The program successfully performed 72 transplants, representing the highest proportion of successful outcomes among all evaluated pathways. Specifically, 35% of the 131 incompatible couples received transplants through this initiative. For highly-immunized patients, the program achieved an 18% success rate, which equaled the performance of the Acceptable Mismatch program. Among 69 long-waiting patients, 20% were transplanted via this new model, while 53% received organs from deceased donors. The total volume of procedures included 66 compatible transplants, 5 blood-type incompatible, and 1 case involving both blood-type and human leukocyte antigen incompatibility. These findings indicate that the approach effectively increases opportunities for difficult-to-match individuals. The data demonstrate that success stems from prioritization rather than expanding the donor pool size. This initiative outperformed other programs in facilitating transplants for the most complex cases.
Conclusions:
The authors suggest that this program serves as a robust tool for addressing transplantation barriers. Their synthesis indicates that prioritization strategies effectively improve access for highly sensitized individuals. The findings imply that allowing specific incompatible allocations expands options without needing larger donor pools. This study demonstrates that the program performs competitively against established clinical alternatives. The researchers propose that integrating such models enhances the overall efficiency of renal allocation systems. Their evidence supports the utility of this approach for patients who are otherwise difficult to match. The results highlight the potential for targeted allocation policies to improve transplant rates. This work provides a framework for future implementations of similar computerized integration strategies in clinical practice.
The researchers propose that the program improves access by prioritizing highly sensitized candidates and permitting specific incompatible transplants. This mechanism allows for successful outcomes in patients who would otherwise remain on waiting lists due to blood type or immune system barriers.
The program utilizes computerized integration to manage allocation, whereas traditional systems rely on standard matching. The authors report that CIAT facilitated 35% of transplants among the studied incompatible couples, outperforming other available clinical programs.
The authors state that strict criteria were necessary to manage risk. Specifically, they permitted AB0-incompatible allocations for long-waiting patients and allowed both AB0- and HLA-incompatible transplants for highly-immunized candidates to ensure safety.
This data type represents the primary cohort, consisting of 131 incompatible couples. The researchers used this group to evaluate the efficacy of the program against other existing options over a five-year period.
The study measured transplant success across different patient categories. For highly-immunized patients, CIAT achieved an 18% transplant rate, matching the performance of the Acceptable Mismatch program, while other initiatives contributed lower percentages.
The authors claim that this model is a powerful addition to current options. They propose that the strategy succeeds by optimizing existing resources through prioritization rather than simply increasing the total number of donors.